Circulating thyrotropin receptor messenger ribonucleic acid is not an effective marker in the follow-up of differentiated thyroid carcinoma

BACKGROUND: Circulating thyrotropin receptor messenger ribonucleic acid (TSHR mRNA) assay has been validated in the follow-up of differentiated thyroid carcinoma (DTC) because of its high sensitivity during thyroid hormone therapy and no interference with endogenous anti-thyroglobulin antibodies (Tg...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Thyroid Res
Main Authors: Ausavarat, Surasawadee, Sriprapaporn, Jiraporn, Satayaban, Busara, Thongnoppakhun, Wanna, Laipiriyakun, Aunchalee, Amornkitticharoen, Boontham, Chanachai, Rujaporn, Pattanachak, Chaveevan
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2015
Assuntos:
Short Report
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4523908/
https://ncbi.nlm.nih.gov/pubmed/26244057
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13044-015-0024-4
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados